Gene Symbol | F2 |
Entrez ID | 2147 |
Uniprot ID | P00734 |
Description | coagulation factor II (thrombin) |
Chromosomal Location | chr11: 46,719,180-46,739,506 |
Ontology | GO ID | GO Term | Definition | Evidence |
---|---|---|---|---|
BP |
GO:0001934 |
positive regulation of protein phosphorylation |
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein. |
IDA |
BP |
GO:0006465 |
signal peptide processing |
The proteolytic removal of a signal peptide from a protein during or after transport to a specific location in the cell. |
TAS |
BP |
GO:0006508 |
proteolysis |
The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds. |
TAS |
BP |
GO:0006888 |
ER to Golgi vesicle-mediated transport |
The directed movement of substances from the endoplasmic reticulum (ER) to the Golgi, mediated by COP II vesicles. Small COP II coated vesicles form from the ER and then fuse directly with the cis-Golgi. Larger structures are transported along microtubules to the cis-Golgi. |
TAS |
BP |
GO:0006953 |
acute-phase response |
An acute inflammatory response that involves non-antibody proteins whose concentrations in the plasma increase in response to infection or injury of homeothermic animals. |
IEA |
BP |
GO:0007166 |
cell surface receptor signaling pathway |
A series of molecular signals initiated by activation of a receptor on the surface of a cell. The pathway begins with binding of an extracellular ligand to a cell surface receptor, or for receptors that signal in the absence of a ligand, by ligand-withdrawal or the activity of a constitutively active receptor. The pathway ends with regulation of a downstream cellular process, e.g. transcription. |
IDA |
BP |
GO:0007275 |
multicellular organism development |
The biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote or a young adult) to a later condition (e.g. a multicellular animal or an aged adult). |
TAS |
BP |
GO:0007596 |
blood coagulation |
The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers. |
TAS |
BP |
GO:0007597 |
blood coagulation, intrinsic pathway |
A protein activation cascade that contributes to blood coagulation and consists of the interactions among high molecular weight kininogen, prekallikrein, and factor XII that lead to the activation of clotting factor X. |
TAS |
BP |
GO:0008284 |
positive regulation of cell proliferation |
Any process that activates or increases the rate or extent of cell proliferation. |
IEA |
BP |
GO:0008360 |
regulation of cell shape |
Any process that modulates the surface configuration of a cell. |
IEA |
BP |
GO:0009611 |
response to wounding |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to the organism. |
IDA |
BP |
GO:0010468 |
regulation of gene expression |
Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. |
IEA |
BP |
GO:0010544 |
negative regulation of platelet activation |
Any process that decreases the rate or frequency of platelet activation. Platelet activation is a series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. |
TAS |
BP |
GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling |
Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade. |
IEA |
BP |
GO:0017187 |
peptidyl-glutamic acid carboxylation |
The gamma-carboxylation of peptidyl-glutamic acid; catalyzed by the vitamin K dependent gamma-glutamyl carboxylase. |
TAS |
BP |
GO:0030168 |
platelet activation |
A series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug. |
IDA|TAS |
BP |
GO:0030193 |
regulation of blood coagulation |
Any process that modulates the frequency, rate or extent of blood coagulation. |
TAS |
BP |
GO:0030194 |
positive regulation of blood coagulation |
Any process that activates or increases the frequency, rate or extent of blood coagulation. |
IDA |
BP |
GO:0030307 |
positive regulation of cell growth |
Any process that activates or increases the frequency, rate, extent or direction of cell growth. |
IEA |
BP |
GO:0032967 |
positive regulation of collagen biosynthetic process |
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals. |
IDA |
BP |
GO:0042730 |
fibrinolysis |
A process that solubilizes fibrin in the bloodstream of a multicellular organism, chiefly by the proteolytic action of plasmin. |
IDA |
BP |
GO:0044267 |
cellular protein metabolic process |
The chemical reactions and pathways involving a specific protein, rather than of proteins in general, occurring at the level of an individual cell. Includes cellular protein modification. |
TAS |
BP |
GO:0045861 |
negative regulation of proteolysis |
Any process that stops, prevents, or reduces the frequency, rate or extent of the hydrolysis of a peptide bond or bonds within a protein. |
IDA |
BP |
GO:0048712 |
negative regulation of astrocyte differentiation |
Any process that stops, prevents, or reduces the frequency, rate or extent of astrocyte differentiation. |
IDA |
BP |
GO:0050900 |
leukocyte migration |
The movement of a leukocyte within or between different tissues and organs of the body. |
TAS |
BP |
GO:0051281 |
positive regulation of release of sequestered calcium ion into cytosol |
Any process that activates or increases the frequency, rate or extent of the release into the cytosolic compartment of calcium ions sequestered in the endoplasmic reticulum or mitochondria. |
IDA |
BP |
GO:0051480 |
regulation of cytosolic calcium ion concentration |
Any process involved in the maintenance of an internal steady state of calcium ions within the cytosol of a cell or between the cytosol and its surroundings. |
IDA |
BP |
GO:0051918 |
negative regulation of fibrinolysis |
Any process that stops, prevents, or reduces the frequency, rate or extent of fibrinolysis, an ongoing process that solubilizes fibrin, resulting in the removal of small blood clots. |
TAS |
BP |
GO:0090218 |
positive regulation of lipid kinase activity |
Any process that increases the frequency, rate or extent of lipid kinase activity, the catalysis of the transfer of a phosphate group, usually from ATP, to a simple or complex lipid. |
IDA |
BP |
GO:1900182 |
positive regulation of protein localization to nucleus |
Any process that activates or increases the frequency, rate or extent of protein localization to nucleus. |
IDA |
BP |
GO:1900738 |
positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway |
Any process that activates or increases the frequency, rate or extent of phospholipase C-activating G-protein coupled receptor signaling pathway. |
IDA |
BP |
GO:2000379 |
positive regulation of reactive oxygen species metabolic process |
Any process that activates or increases the frequency, rate or extent of reactive oxygen species metabolic process. |
IDA |
CC |
GO:0005576 |
extracellular region |
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
TAS |
CC |
GO:0005615 |
extracellular space |
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
IDA |
CC |
GO:0005788 |
endoplasmic reticulum lumen |
The volume enclosed by the membranes of the endoplasmic reticulum. |
TAS |
CC |
GO:0005796 |
Golgi lumen |
The volume enclosed by the membranes of any cisterna or subcompartment of the Golgi apparatus, including the cis- and trans-Golgi networks. |
TAS |
CC |
GO:0005886 |
plasma membrane |
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
TAS |
CC |
GO:0070062 |
extracellular exosome |
A membrane-bounded vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. |
IDA |
CC |
GO:0072562 |
blood microparticle |
A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids. |
IDA |
MF |
GO:0004252 |
serine-type endopeptidase activity |
Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine). |
IDA|TAS |
MF |
GO:0005102 |
receptor binding |
Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function. |
IPI |
MF |
GO:0005509 |
calcium ion binding |
Interacting selectively and non-covalently with calcium ions (Ca2+). |
IEA |
MF |
GO:0005515 |
protein binding |
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
IPI |
MF |
GO:0008083 |
growth factor activity |
The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation. |
TAS |
MF |
GO:0070053 |
thrombospondin receptor activity |
Combining with thrombospondin and transmitting the signal to initiate a change in cell activity. |
IDA |
Domain ID | Description |
---|---|
IPR000001 |
Kringle |
IPR000294 |
Gamma-carboxyglutamic acid-rich (GLA) domain |
IPR001254 |
Serine proteases, trypsin domain |
IPR001314 |
Peptidase S1A, chymotrypsin family |
IPR003966 |
Prothrombin/thrombin |
IPR009003 |
Peptidase S1, PA clan |
IPR013806 |
Kringle-like fold |
IPR017857 |
Coagulation factor, subgroup, Gla domain |
IPR018056 |
Kringle, conserved site |
IPR018114 |
Serine proteases, trypsin family, histidine active site |
IPR018992 |
Thrombin light chain |
IPR033116 |
Serine proteases, trypsin family, serine active site |
Pathway ID | Pathway Term | Pathway Source |
---|---|---|
hsa04080 |
Neuroactive ligand-receptor interaction |
KEGG |
hsa04610 |
Complement and coagulation cascades |
KEGG |
hsa04810 |
Regulation of actin cytoskeleton |
KEGG |
WP1533 |
Vitamin B12 Metabolism |
WikiPathways |
WP15 |
Selenium Micronutrient Network |
WikiPathways |
WP2865 |
IL1 and megakaryocytes in obesity |
WikiPathways |
WP272 |
Blood Clotting Cascade |
WikiPathways |
WP51 |
Regulation of Actin Cytoskeleton |
WikiPathways |
WP176 |
Folate Metabolism |
WikiPathways |
WP558 |
Complement and Coagulation Cascades |
WikiPathways |
h_amiPathway |
Acute Myocardial Infarction |
BioCarta |
h_sppaPathway |
Aspirin Blocks Signaling Pathway Involved in Platelet Activation |
BioCarta |
h_biopeptidesPathway |
Bioactive Peptide Induced Signaling Pathway |
BioCarta |
h_extrinsicPathway |
Extrinsic Prothrombin Activation Pathway |
BioCarta |
h_fibrinolysisPathway |
Fibrinolysis Pathway |
BioCarta |
h_intrinsicPathway |
Intrinsic Prothrombin Activation Pathway |
BioCarta |
h_nfatPathway |
NFAT and Hypertrophy of the heart (Transcription in the broken heart) |
BioCarta |
h_plateletAppPathway |
Platelet Amyloid Precursor Protein Pathway |
BioCarta |
h_Par1Pathway |
Thrombin signaling and protease-activated receptors |
BioCarta |
h_dbpbPathway |
Transcriptional activation of dbpb from mRNA |
BioCarta |
UMLS CUI | UMLS Term |
---|---|
C0002395 |
Alzheimer'S Disease |
C0003873 |
Rheumatoid Arthritis |
C0005779 |
Blood Coagulation Disorders |
C0007785 |
Cerebral Infarction |
C0007786 |
Brain Ischemia |
C0012739 |
Disseminated Intravascular Coagulation |
C0015695 |
Fatty Liver |
C0019080 |
Hemorrhage |
C0020640 |
Inherited Factor Ii Deficiency |
C0023890 |
Liver Cirrhosis |
C0027051 |
Myocardial Infarction |
C0027720 |
Nephrosis |
C0027746 |
Nerve Degeneration |
C0028754 |
Obesity |
C0030524 |
Paratuberculosis |
C0037198 |
Sinus Thrombosis, Intracranial |
C0038454 |
Cerebrovascular Accident |
C0040038 |
Thromboembolism |
C0040053 |
Thrombosis |
C0042487 |
Venous Thrombosis |
C0085605 |
Liver Failure |
C0162819 |
Skin Diseases, Vascular |
C0398623 |
Thrombophilia |
C0400966 |
Non-Alcoholic Fatty Liver Disease |
C1861172 |
Venous Thromboembolism |
C2239176 |
Liver Carcinoma |
Database Name |
---|
DisGeNET |
DGA |
Pubmed ID | Author | Year | Title |
---|---|---|---|
15291743 |
Diao et al. |
2004 |
The molecular characteristics of polycystic ovary syndrome (PCOS) ovary defined by human ovary cDNA microarray |
25393639 |
Ambekar et al. |
2014 |
Proteomics of follicular fluid from women with polycystic ovary syndrome suggests molecular defects in follicular development |
Gene Symbol | Entrez ID | Uniprot ID | Score |
---|---|---|---|
GP9 |
2815 |
P14770 |
0.00 |
AANAT |
15 |
Q16613 |
0.52 |
AMBP |
259 |
P02760 |
0.52 |
F2 |
2147 |
P00734 |
0.52 |
F2RL1 |
2150 |
P55085 |
0.52 |
F13A1 |
2162 |
P00488 |
0.52 |
HGFAC |
3083 |
Q04756 |
0.52 |
PROC |
5624 |
P04070 |
0.52 |
PROS1 |
5627 |
P07225 |
0.52 |
ST13 |
6767 |
P50502 |
0.55 |
AKR7A2 |
8574 |
O43488 |
0.55 |
PLAU |
5328 |
P00749 |
0.62 |
PROZ |
8858 |
P22891 |
0.62 |
DDIT3 |
1649 |
P35638 |
0.63 |
SPP1 |
6696 |
P10451 |
0.65 |
SERPINC1 |
462 |
P01008 |
0.84 |
F2R |
2149 |
P25116 |
0.84 |
CPB2 |
1361 |
Q96IY4 |
0.85 |
SERPINE1 |
5054 |
P05121 |
0.86 |
SERPINB6 |
5269 |
P35237 |
0.86 |
SERPIND1 |
3053 |
P05546 |
0.88 |
FGA |
2243 |
P02671 |
0.89 |
A2M |
2 |
P01023 |
0.00 |
F10 |
2159 |
P00742 |
0.00 |
F13B |
2165 |
P05160 |
0.00 |
C6 |
729 |
P13671 |
0.52 |
F2RL2 |
2151 |
O00254 |
0.52 |
F9 |
2158 |
P00740 |
0.52 |
F11 |
2160 |
P03951 |
0.52 |
GP5 |
2814 |
P40197 |
0.52 |
KNG1 |
3827 |
P01042 |
0.52 |
SERPINE2 |
5270 |
P07093 |
0.52 |
SERPINB8 |
5271 |
P50452 |
0.52 |
F2RL3 |
9002 |
Q96RI0 |
0.52 |
GGCX |
2677 |
P38435 |
0.62 |
IGFBP5 |
3488 |
P24593 |
0.62 |
FN1 |
2335 |
P02751 |
0.63 |
IGFBP3 |
3486 |
P17936 |
0.65 |
C1QBP |
708 |
Q07021 |
0.68 |
ALB |
213 |
P02768 |
0.72 |
SERPING1 |
710 |
P05155 |
0.75 |
ITGA2B |
3674 |
P08514 |
0.75 |
THBS1 |
7057 |
P07996 |
0.75 |
PLAT |
5327 |
P00750 |
0.78 |
F8 |
2157 |
P00451 |
0.80 |
SERPINA5 |
5104 |
P05154 |
0.83 |
GP1BA |
2811 |
P07359 |
0.84 |
F5 |
2153 |
P12259 |
0.86 |
THBD |
7056 |
P07204 |
0.90 |